COMMODORE CAPITAL LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Bright Minds Biosciences Inc. (DRUG)

Filing Manager
COMMODORE CAPITAL LP
Reporting Manager
COMMODORE CAPITAL LP
Security
Bright Minds Biosciences Inc. Common Shares, without par value
Symbol
DRUG
Shares outstanding
6.94M shares
Disclosed Ownership
500K shares
Ownership
7.2%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:05 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
COMMODORE CAPITAL LP 7.2% 500K 0 500K /s/ Michael Kramarz Michael Kramarz, Managing Partner
Commodore Capital Master LP 7.2% 500K 0 500K /s/ Michael Kramarz Michael Kramarz, Authorized Signatory